185 related articles for article (PubMed ID: 24448396)
1. Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.
Chenoweth MJ; Zhu AZ; Sanderson Cox L; Ahluwalia JS; Benowitz NL; Tyndale RF
Pharmacogenet Genomics; 2014 Mar; 24(3):172-6. PubMed ID: 24448396
[TBL] [Abstract][Full Text] [Related]
2. Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking.
Mwenifumbo JC; Sellers EM; Tyndale RF
Drug Alcohol Depend; 2007 Jun; 89(1):24-33. PubMed ID: 17161559
[TBL] [Abstract][Full Text] [Related]
3. Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.
Taghavi T; St Helen G; Benowitz NL; Tyndale RF
Pharmacogenet Genomics; 2017 Apr; 27(4):143-154. PubMed ID: 28178031
[TBL] [Abstract][Full Text] [Related]
4. An association of CYP2A6 genotype and smoking topography.
Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
[TBL] [Abstract][Full Text] [Related]
5. New CYP2A6 gene deletion and conversion variants in a population of Black African descent.
Mwenifumbo JC; Zhou Q; Benowitz NL; Sellers EM; Tyndale RF
Pharmacogenomics; 2010 Feb; 11(2):189-98. PubMed ID: 20136358
[TBL] [Abstract][Full Text] [Related]
6. Nicotine-
Perez-Paramo YX; Chen G; Ashmore JH; Watson CJW; Nasrin S; Adams-Haduch J; Wang R; Gao YT; Koh WP; Yuan JM; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):311-320. PubMed ID: 30381441
[TBL] [Abstract][Full Text] [Related]
7. Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.
Piliguian M; Zhu AZ; Zhou Q; Benowitz NL; Ahluwalia JS; Sanderson Cox L; Tyndale RF
Pharmacogenet Genomics; 2014 Feb; 24(2):118-28. PubMed ID: 24305170
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors.
Tanner JA; Prasad B; Claw KG; Stapleton P; Chaudhry A; Schuetz EG; Thummel KE; Tyndale RF
J Pharmacol Exp Ther; 2017 Jan; 360(1):129-139. PubMed ID: 27815364
[TBL] [Abstract][Full Text] [Related]
9. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Ho MK; Mwenifumbo JC; Al Koudsi N; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2009 Jun; 85(6):635-43. PubMed ID: 19279561
[TBL] [Abstract][Full Text] [Related]
10. Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain.
Teitelbaum AM; Murphy SE; Akk G; Baker TB; Germann A; von Weymarn LB; Bierut LJ; Goate A; Kharasch ED; Bloom AJ
Pharmacogenomics J; 2018 Jan; 18(1):136-143. PubMed ID: 28290528
[TBL] [Abstract][Full Text] [Related]
11. Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption.
Bloom AJ; Murphy SE; Martinez M; von Weymarn LB; Bierut LJ; Goate A
Pharmacogenet Genomics; 2013 Feb; 23(2):62-8. PubMed ID: 23211429
[TBL] [Abstract][Full Text] [Related]
12. A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.
Ho MK; Mwenifumbo JC; Zhao B; Gillam EM; Tyndale RF
Pharmacogenet Genomics; 2008 Jan; 18(1):67-75. PubMed ID: 18216723
[TBL] [Abstract][Full Text] [Related]
13. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.
Mwenifumbo JC; Lessov-Schlaggar CN; Zhou Q; Krasnow RE; Swan GE; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2008 Jan; 83(1):115-21. PubMed ID: 17522595
[TBL] [Abstract][Full Text] [Related]
15. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent.
Mwenifumbo JC; Al Koudsi N; Ho MK; Zhou Q; Hoffmann EB; Sellers EM; Tyndale RF
Hum Mutat; 2008 May; 29(5):679-88. PubMed ID: 18360915
[TBL] [Abstract][Full Text] [Related]
16. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
Nakajima M; Fukami T; Yamanaka H; Higashi E; Sakai H; Yoshida R; Kwon JT; McLeod HL; Yokoi T
Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
[TBL] [Abstract][Full Text] [Related]
18. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
[TBL] [Abstract][Full Text] [Related]
19. A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
Fukami T; Nakajima M; Yoshida R; Tsuchiya Y; Fujiki Y; Katoh M; McLeod HL; Yokoi T
Clin Pharmacol Ther; 2004 Dec; 76(6):519-27. PubMed ID: 15592323
[TBL] [Abstract][Full Text] [Related]
20. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.
Zhu AZ; Renner CC; Hatsukami DK; Swan GE; Lerman C; Benowitz NL; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):708-18. PubMed ID: 23371292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
